Comparison of the dynamics of exoskeletal-assisted and unassisted locomotion in an FDA-approved lower extremity device: Controlled experiments and development of a subject-specific... von Chandran, Vishnu D, Nam, Sanghyun, Hexner, David, Bauman, William A, Pal, Saikat

Volltext

Dataset for: Comparison of the dynamics of exoskeletal-assisted and unassisted locomotion in an FDA-approved lower extremity device: Controlled experiments and development of a sub... von Chandran, Vishnu Deep, Nam, Sanghyun, Hexner, David, Bauman, William, Pal, Saikat

Volltext bestellen

Dataset for comparison of the dynamics of exoskeletal-assisted and unassisted locomotion in an FDA-approved lower extremity device: Controlled experiments and development of a subj... von Chandran, Vishnu Deep, Nam, Sanghyun, Hexner, David, Bauman, William, Pal, Saikat

Volltext bestellen

Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group von Soderquist, Craig R, Ewalt, Mark D, Czuchlewski, David R, Geyer, Julia T, Rogers, Heesun J, Hsi, Eric D, Wang, Sa A, Bueso-Ramos, Carlos E, Orazi, Attilio, Arber, Daniel A, Hexner, Elizabeth O, Babushok, Daria V, Bagg, Adam

Volltext

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia von Frey, Noelle V, Gill, Saar, Hexner, Elizabeth O, Schuster, Stephen, Nasta, Sunita, Loren, Alison, Svoboda, Jakub, Stadtmauer, Edward, Landsburg, Daniel J, Mato, Anthony, Levine, Bruce L, Lacey, Simon F, Melenhorst, Jan Joseph, Veloso, Elizabeth, Gaymon, Avery, Pequignot, Edward, Shan, Xinhe, Hwang, Wei-Ting, June, Carl H, Porter, David L

Volltext

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia von Frey, Noelle V, Shaw, Pamela A, Hexner, Elizabeth O, Pequignot, Edward, Gill, Saar, Luger, Selina M, Mangan, James K, Loren, Alison W, Perl, Alexander E, Maude, Shannon L, Grupp, Stephan A, Shah, Nirav N, Gilmore, Joan, Lacey, Simon F, Melenhorst, Jos J, Levine, Bruce L, June, Carl H, Porter, David L

Volltext

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease von Reshef, Ran, Luger, Selina M, Hexner, Elizabeth O, Loren, Alison W, Frey, Noelle V, Nasta, Sunita D, Goldstein, Steven C, Stadtmauer, Edward A, Smith, Jacqueline, Bailey, Sarah, Mick, Rosemarie, Heitjan, Daniel F, Emerson, Stephen G, Hoxie, James A, Vonderheide, Robert H, Porter, David L

Volltext

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia von Matthews, Andrew H., Perl, Alexander E., Luger, Selina M., Loren, Alison W., Gill, Saar I., Porter, David L., Babushok, Daria V., Maillard, Ivan P., Carroll, Martin P., Frey, Noelle V., Hexner, Elizabeth O., Martin, Mary Ellen, McCurdy, Shannon R., Stadtmauer, Edward A., Paralkar, Vikram R., Bruno, Ximena Jordan, Hwang, Wei-Ting, Margolis, David, Pratz, Keith W.

Volltext

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis von Gotlib, Jason, Kluin-Nelemans, Hanneke C, George, Tracy I, Akin, Cem, Sotlar, Karl, Hermine, Olivier, Awan, Farrukh T, Hexner, Elizabeth, Mauro, Michael J, Sternberg, David W, Villeneuve, Matthieu, Huntsman Labed, Alice, Stanek, Eric J, Hartmann, Karin, Horny, Hans-Peter, Valent, Peter, Reiter, Andreas

Volltext

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia von Myers, Regina M, Li, Yimei, Barz Leahy, Allison, Barrett, David M, Teachey, David T, Callahan, Colleen, Fasano, Christina C, Rheingold, Susan R, DiNofia, Amanda, Wray, Lisa, Aplenc, Richard, Baniewicz, Diane, Liu, Hongyan, Shaw, Pamela A, Pequignot, Edward, Getz, Kelly D, Brogdon, Jennifer L, Fesnak, Andrew D, Siegel, Donald L, Davis, Megan M, Bartoszek, Chelsie, Lacey, Simon F, Hexner, Elizabeth O, Chew, Anne, Wertheim, Gerald B, Levine, Bruce L, June, Carl H, Grupp, Stephan A, Maude, Shannon L

Volltext

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy von Ghilardi, Guido, Fraietta, Joseph A., Gerson, James N., Van Deerlin, Vivianna M., Morrissette, Jennifer J. D., Caponetti, Gabriel C., Paruzzo, Luca, Harris, Jaryse C., Chong, Elise A., Susanibar Adaniya, Sandra P., Svoboda, Jakub, Nasta, Sunita D., Ugwuanyi, Ositadimma H., Landsburg, Daniel J., Fardella, Eugenio, Waxman, Adam J., Chong, Emeline R., Patel, Vrutti, Pajarillo, Raymone, Kulikovskaya, Irina, Lieberman, David B., Cohen, Adam D., Levine, Bruce L., Stadtmauer, Edward A., Frey, Noelle V., Vogl, Dan T., Hexner, Elizabeth O., Barta, Stefan K., Porter, David L., Garfall, Alfred L., Schuster, Stephen J., June, Carl H., Ruella, Marco

Volltext

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease von Srinagesh, Hrishikesh K., Özbek, Umut, Kapoor, Urvi, Ayuk, Francis, Aziz, Mina, Ben-David, Kaitlyn, Choe, Hannah K., DeFilipp, Zachariah, Etra, Aaron, Grupp, Stephan A., Hartwell, Matthew J., Hexner, Elizabeth O., Hogan, William J., Karol, Alexander B., Kasikis, Stelios, Kitko, Carrie L., Kowalyk, Steven, Lin, Jung-Yi, Major-Monfried, Hannah, Mielke, Stephan, Merli, Pietro, Morales, George, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reddy, Pavan, Reshef, Ran, Rösler, Wolf, Sandhu, Karamjeet S., Schechter, Tal, Shah, Jay, Sigel, Keith, Weber, Daniela, Wölfl, Matthias, Wudhikarn, Kitsada, Young, Rachel, Levine, John E., Ferrara, James L.M.

Volltext

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results von Bagley, Stephen J., Logun, Meghan, Fraietta, Joseph A., Wang, Xin, Desai, Arati S., Bagley, Linda J., Nabavizadeh, Ali, Jarocha, Danuta, Martins, Rene, Maloney, Eileen, Lledo, Lester, Stein, Carly, Marshall, Amy, Leskowitz, Rachel, Jadlowsky, Julie K., Christensen, Shannon, Oner, Bike Su, Plesa, Gabriela, Brennan, Andrea, Gonzalez, Vanessa, Chen, Fang, Sun, Yusha, Gladney, Whitney, Barrett, David, Nasrallah, MacLean P., Hwang, Wei-Ting, Ming, Guo-Li, Song, Hongjun, Siegel, Donald L., June, Carl H., Hexner, Elizabeth O., Binder, Zev A., O’Rourke, Donald M.

Volltext

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract von Ganetsky, Alex, Frey, Noelle V., Hexner, Elizabeth O., Loren, Alison W., Gill, Saar I., Luger, Selina M., Mangan, James K., Martin, Mary Ellen, Babushok, Daria V., Drobyski, William R., Smith, Jacqueline, Timlin, Colleen, Freyer, Craig W., Stadtmauer, Edward A., Porter, David L.

Volltext

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia von Connor, Matthew P, Prathapa, Neeharika, Frey, Noelle V, Gill, Saar I, Hexner, Elizabeth O, Bruno, Ximena Jordan, Lai, Catherine E, Loren, Alison W, Luger, Selina M, Matthews, Andrew H, McCurdy, Shannon R, Perl, Alexander E, Porter, David L, Zeringue, Arlene, Oved, Joseph H, Olson, Timothy S, Pratz, Keith W, Babushok, Daria V

Volltext

Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients von Ganetsky, Alex, Han, Jennifer H, Hughes, Mitchell E, Babushok, Daria V, Frey, Noelle V, Gill, Saar I, Hexner, Elizabeth O, Loren, Alison W, Luger, Selina M, Mangan, James K, Martin, Mary Ellen, Smith, Jacqueline, Freyer, Craig W, Gilmar, Cheryl, Schuster, Mindy, Stadtmauer, Edward A, Porter, David L

Volltext

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD von Wang, Ying, He, Shan, Calendo, Gennaro, Bui, Tien, Tian, Yuanyuan, Lee, Che Young, Zhou, Yan, Zhao, Xin, Abraham, Ciril, Mo, Wenbin, Chen, Mimi, Sanders-Braggs, Ruqayyah, Madzo, Jozef, Issa, Jean-Pierre, Hexner, Elizabeth O, Wiest, David L, Reshef, Ran, Xue, Hai-Hui, Zhang, Yi

Volltext

Germline POT1 variants can predispose to myeloid and lymphoid neoplasms von Lim, Tristan L., Lieberman, David B., Davis, Adam R., Loren, Alison W., Hausler, Ryan, Bigdeli, Ashkan, Li, Yimei, Powers, Jacquelyn, Raper, Anna, Regeneron Genetics Center, Carty, Shannon A., Nathanson, Katherine L., Bagg, Adam, Hexner, Elizabeth O., Maxwell, Kara N., Morrissette, Jennifer J. D., Babushok, Daria V.

Volltext

Cytokine-mediated CAR T therapy resistance in AML von Bhagwat, Anand S., Torres, Leonel, Shestova, Olga, Shestov, Maksim, Mellors, Patrick W., Fisher, Han R., Farooki, Saamia N., Frost, Benjamin F., Loken, Michael R., Gaymon, Avery L., Frazee, Diane, Rogal, Walter, Frey, Noelle, Hexner, Elizabeth O., Luger, Selina M., Loren, Alison W., Martin, Mary Ellen, McCurdy, Shannon R., Perl, Alexander E., Stadtmauer, Edward A., Brogdon, Jennifer L., Fraietta, Joseph A., Hwang, Wei-Ting, Siegel, Don L., Plesa, Gabriela, Aplenc, Richard, Porter, David L., June, Carl H., Gill, Saar I.

Volltext

Salvage therapy with basiliximab and etanercept for severe steroid‐refractory acute graft‐versus‐host disease von Freyer, Craig W., Gier, Shannon, Carulli, Alison, Gill, Saar I., Hexner, Elizabeth O., Loren, Alison W., Martin, Mary Ellen, Porter, David L.

Volltext